Definitive Contract W81XWH19C0051
Award Date 4/15/19
Potential Completion Date 6/14/23
Potential Value $948K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Farmingdale, NY 11735, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
8
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
SBIR Program Phase II Action
Primary Consortia Member
Not listed Similar Awards
- This $148,851.02 firm fixed-price Small Business Innovation Research (SBIR) Phase I contract was awarded by the U.S. Army Medical Command (MEDCOM) to Codagenix Inc., a clinical-stage biotechnology company. The contract is for the development of a balanced and efficacious live-attenuated tetravalent dengue vaccine. Codagenix has received additional federal funding, including a $389.4 million contract from the Department of Health and Human Services for a Phase 2B COVID-19 vaccine study and...
- The Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response awarded a $389.4 million cost-plus-fixed-fee definitive contract to Codagenix Inc. on September 30, 2023, to conduct a Phase 2B efficacy study of Coviliv, a proprietary live attenuated virus COVID-19 vaccine developed using the company's Synthetic Attenuated Virus Engineering platform. Under this contract, which has no set-aside designation, Codagenix will also manufacture SARS-CoV-2...
- This is a $2,574,853.28 Firm Fixed Price contract awarded by the Department of the Army Medical Command to Technovax Inc., a Minority Owned, Self Certified Small Disadvantaged Business, for the "Next-Generation Adenovirus Vaccine" under the ARMY 15.1 SBIR (Small Business Innovation Research) program. The contract is set aside for Small Businesses and has a period of performance through March 31, 2023. The contract is associated with the National Interest Action Code for the Coronavirus...
- This is a definitive contract awarded by the Department of the Army's Aberdeen Proving Ground Contracting Command to Novavax Inc., a biotechnology company that develops and produces recombinant protein nanoparticle vaccines. The $36,042,001.44 contract is for vaccine development and production related to the COVID-19 response, with a period of performance through December 2022. This contract is not set aside for any specific business type. Novavax has also received Indefinite Delivery Vehicle...
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the U.S. Army Medical Command (MEDCOM) to Protein Sciences Corp, a for-profit manufacturer located in Meriden, Connecticut. The $149,999.05 fixed-price contract is for research and development in support of pandemic preparedness, including preclinical and clinical trials of COVID-19 and H7 vaccine candidates, as well as manufacturing and analytical services. Protein Sciences has received multiple past awards from the...
- The Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response awarded a $29.9 million delivery order to Protein Sciences Corporation under the Pandemic Influenza Preparedness and Response 2016-2021 master IDIQ contract. The delivery order is for non-clinical and Phase I clinical studies of a stabilized pre-fusion trimer of the spike protein COVID-19 vaccine candidate reconstituted with two adjuvants, AS03 and AF03, to be performed in Meriden,...
- This contract was awarded by the Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases to Codex Biosolutions Inc., a minority-owned small disadvantaged business, to identify cellular factors that impact the production of a full-length HIV-1 envelope trimer without altering its native antigenic properties. The $599,424.00 firm-fixed-price contract is funded through the Small Business Innovation Research (SBIR) program and...
- This federal contract award, valued at $7,521,000.00, was issued by the Centers for Disease Control and Prevention (CDC) to Protein Sciences Corp, a for-profit manufacturer, to conduct research, development, manufacturing, and testing of vaccine candidates, antigens, proteins, seed lots, and assays to support medical countermeasure preparedness against influenza strains and COVID-19. The award is part of the Department of Health and Human Services' (HHS) Office of the Assistant Secretary for...
- This contract award was issued by the Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases to Dynport Vaccine Company LLC, a subsidiary of General Dynamics Corp. The $136,259.00 award is a delivery order under the Therapeutics Against Infectious Diseases Phase 1 contract, which funds a Phase 1 clinical trial unit for therapeutics against infectious diseases. The contract type is cost plus fixed fee, and there is no...
- <p>This is a $1,999,175.53 firm fixed-price Definitive Contract awarded by the Defense Health Agency (DHA), a defense agency, to Technovax Inc., a small disadvantaged business, under the SBIR (Small Business Innovation Research) Phase II program. The contract is for research and development work, with a period of performance ending on February 16, 2021. The contract was set aside for small businesses.</p>